Meropenem Dosing for 2.5-Month-Old Infant Weighing 2.6 kg
For this 2.5-month-old infant weighing 2.6 kg, administer meropenem 20 mg/kg every 12 hours (52 mg per dose every 12 hours), given as an intravenous infusion over 30 minutes. 1, 2
Dosing Algorithm Based on Age and Weight
This infant falls into a specific neonatal dosing category that requires careful consideration of both gestational age (GA) and postnatal age (PNA):
Step 1: Determine Gestational and Postnatal Age Category
- If gestational age <32 weeks AND postnatal age <14 days: 20 mg/kg every 12 hours 1
- If gestational age <32 weeks AND postnatal age ≥14 days: 20 mg/kg every 8 hours 1
- If gestational age ≥32 weeks AND postnatal age <14 days: 20 mg/kg every 8 hours 1
- If gestational age ≥32 weeks AND postnatal age ≥14 days: 30 mg/kg every 8 hours 1
Step 2: Calculate Actual Dose
For this 2.6 kg infant at 2.5 months (approximately 10 weeks) postnatal age:
- Most likely scenario (term infant): 30 mg/kg every 8 hours = 78 mg per dose every 8 hours 1
- If premature (<32 weeks GA): 20 mg/kg every 8 hours = 52 mg per dose every 8 hours 1
Step 3: Administration Guidelines
- Administer as intravenous infusion over 30 minutes 2
- Do not administer as bolus injection in infants less than 3 months of age 2
- Reconstitute with Sterile Water for Injection to achieve appropriate concentration 2
Critical Considerations for This Patient
Weight-Based Concerns
This infant's weight of 2.6 kg at 2.5 months of age is significantly below expected norms and suggests:
- Prematurity is highly likely - most term infants weigh 4-6 kg at this age 3
- Renal function assessment is essential - serum creatinine should guide dosing adjustments 3, 4
- Fluid overload status should be evaluated - though research suggests it may not significantly affect target attainment 5
Pharmacokinetic Optimization
The dosing must account for postmenstrual age (PMA) and renal function: 3, 4
- Meropenem clearance increases with postmenstrual age: CL (L/h/kg) = 0.041 + 0.040/SCr + 0.003 × (PCA-35) 4
- For adequate bacterial killing, maintain free drug concentrations >MIC for 40-75% of the dosing interval 3, 4
- The 20-30 mg/kg every 8-12 hour regimen achieves therapeutic targets in >90% of neonates 3, 4
Common Pitfalls to Avoid
- Do not use the standard pediatric dose of 10 mg/kg every 8 hours - this is only for children ≥3 months with complicated skin/soft tissue infections 2
- Do not assume normal renal function - obtain serum creatinine before dosing, as clearance is strongly associated with renal function 3, 4
- Do not administer as bolus injection - infants <3 months require 30-minute infusions 2
- Do not use adult dosing adjustments - neonatal pharmacokinetics differ substantially from older children and adults 3, 4
Indication-Specific Adjustments
If treating meningitis (not specified in question):
- Dose would be 40 mg/kg every 8 hours for children ≥3 months 2
- However, there is no established meningitis dosing for infants <3 months in the FDA label 2
- Meropenem achieves 70% CSF penetration in infants 3
If treating complicated intra-abdominal infection:
Monitoring Requirements
- Obtain baseline serum creatinine before initiating therapy 3, 4
- Monitor renal function during treatment, especially if therapy extends beyond 48-72 hours 4
- Assess clinical response within 24-48 hours and adjust based on culture results 6
- Consider therapeutic drug monitoring in critically ill infants or those with suspected resistant organisms 6, 7